EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 255.1 ILa | -1.58% |
|
+8.65% | -14.91% |
| 04-02 | Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd | CI |
| 03-20 | Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq | MT |
Chart calendar Evogene Ltd.
eb9acf5b4a17c917dcab85788c.uRa31ojQgvxCoSiEGMIVY4mPL463Zux7XZ5k4er6DNo.wFz7rt2Y8pc740ngW6o4Ob_VGcrSEJtKEak-1JyVQOiAffWVxP3EyB3qZQ~f0560032a0c6b595e865d4aa426d8213
Upcoming events on Evogene Ltd.
Past events on Evogene Ltd.
| 2024-03-16 | Roth Conference |
| 2024-03-07 09:00 | Q4 2023 Earnings Call |
| 2024-03-07 07:00 | Q4 2023 Earnings Release |
| 2024-02-01 11:15 | Microbiome Movement Drug Development Summit |
| 2024-01-30 10:30 | Microbiome Movement Drug Development Summit |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-11-15 09:00 | Q3 2023 Earnings Call |
| 2023-11-15 07:00 | Q3 2023 Earnings Release |
| 2023-08-17 09:00 | Q2 2023 Earnings Call |
| 2023-08-17 07:00 | Q2 2023 Earnings Release |
| 2023-05-18 09:00 | Q1 2023 Earnings Call |
| 2023-05-18 07:00 | Q1 2023 Earnings Release |
| 2023-03-21 10:40 | Pharmabiotics Conference |
| 2021-05-26 09:00 | Q1 2021 Earnings Call |
| 2021-05-26 07:00 | Q1 2021 Earnings Release |
| 2021-04-21 | Jefferies Microbiome-based Therapeutics Summit |
| 2021-04-21 09:00 | Investor & Analyst Day |
| 2021-03-03 09:00 | FY 2020 Earnings Call |
| 2021-03-03 07:00 | FY 2020 Earnings Release |
| 2021-01-23 14:00 | Crohn & Colitis Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 1,04 0,00 - | 0,93 0,61 51.47% | 1,68 1,57 6.69% | 5,64 5,54 1.86% | 17,0 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -22,0 -21,8 -0.92% | -17,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -24,8 -24,0 -3.39% | -31,0 -28,9 -7% | -26,9 -31,8 15.39% | -26,5 -26,4 -0.49% | -22,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -26,2 -23,0 -13.8% | -30,4 -30,6 0.52% | -29,8 -34,0 12.49% | -26,0 -26,0 0.09% | -22,9 |
|
Net income Million USD | Released Forecast Spread | -18,1 | -23,4 -23,0 -1.63% | -27,8 -29,0 4.18% | -26,6 -31,2 14.73% | -23,9 -25,0 4.59% | -20,9 |
|
EPS USD | Released Forecast Spread | -0,70 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
| Announcement Date | 04/03/20 | 03/03/21 | 10/03/22 | 09/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,31 0,17 85.48% | 0,24 0,31 -23.3% | 0,31 0,22 41.39% | 0,47 0,28 65.25% | 0,66 0,55 20% | 0,64 0,69 -6.42% | 0,65 0,89 -26.1% | 3,77 1,18 218.34% | 0,58 0,48 21.68% | 3,50 | 2,50 | 8,00 | 3,00 | 2,50 |
|
EBITDA Million USD | Released Forecast Spread | -5,74 -5,95 3.58% | -6,45 -6,05 -6.66% | -2,98 -6,30 52.75% | -6,85 -6,33 -8.33% | -3,55 | -5,33 | -3,50 | -5,35 | ||||||
|
EBIT Million USD | Released Forecast Spread | -8,69 -8,71 0.21% | -8,06 -8,09 0.41% | -8,01 -8,21 2.49% | -7,10 -8,70 18.38% | -3,78 -8,75 56.78% | -6,80 -7,85 13.37% | -7,90 -7,98 0.93% | -4,18 -7,67 45.46% | -7,63 -7,49 -1.88% | -4,85 | -6,63 | -4,80 | -6,65 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,09 -8,57 5.6% | -9,10 -8,75 -4.08% | -9,72 -8,29 -17.17% | -7,16 -8,38 14.56% | -3,78 -8,00 52.8% | -7,03 -7,10 1.04% | -7,76 -7,98 2.73% | -3,86 -7,64 49.42% | -7,34 -7,34 -0.05% | -4,85 | -6,63 | -4,80 | -6,65 | |
|
Net income Million USD | Released Forecast Spread | -7,37 -8,16 9.64% | -9,11 -7,61 -19.72% | -8,82 -7,71 -14.45% | -6,54 -8,46 22.69% | -3,00 -8,28 63.79% | -6,27 -7,60 17.43% | -7,02 -7,29 3.66% | -3,98 -7,21 44.77% | -6,60 -7,09 6.86% | -4,35 | -6,13 | -4,30 | -6,15 | |
| Announcement Date | 10/03/22 | 26/05/22 | 31/08/22 | 17/11/22 | 09/03/23 | 18/05/23 | 17/08/23 | 15/11/23 | 07/03/24 | - | - | - | - | - |
| Today 16:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Evogene Ltd.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- EVGN Stock
- Calendar Evogene Ltd.
